{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:36:17Z","timestamp":1777599377534,"version":"3.51.4"},"reference-count":0,"publisher":"BioExcel","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DIC"],"DOI":"10.7573\/dic.212580","type":"journal-article","created":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T09:01:41Z","timestamp":1554886901000},"page":"1-11","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?"],"prefix":"10.7573","volume":"8","author":[{"given":"Francesco","family":"Menzella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirella","family":"Biava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Galeone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Simonazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Facciolongo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10047","published-online":{"date-parts":[[2019,4,15]]},"container-title":["Drugs in Context"],"original-title":[],"link":[{"URL":"https:\/\/www.drugsincontext.com\/wp-content\/uploads\/2019\/04\/dic.212580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T15:02:31Z","timestamp":1578668551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.drugsincontext.com\/efficacy-and-steroid-sparing-effect-of-benralizumab:-has-it-an-advantage-over-its-competitors?"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":0,"URL":"https:\/\/doi.org\/10.7573\/dic.212580","relation":{},"ISSN":["1740-4398"],"issn-type":[{"value":"1740-4398","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}